JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

JPM

243.31

+0.43%↑

AXP

265.57

+0.87%↑

RY

117.1

+0.45%↑

MMC

214.96

-1.45%↓

TD

62.11

+0.32%↑

Search

KKR & Co LP

Open

BrancheFinanzen

113.47 1.09

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

111.62

Max

114.01

Schlüsselkennzahlen

By Trading Economics

Einkommen

784M

1.4B

Verkäufe

-1.5B

3.2B

KGV

Branchendurchschnitt

29.863

20.525

EPS

1.32

Dividendenrendite

0.71

Gewinnspanne

43.254

Angestellte

4,834

EBITDA

45M

2.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+31.54% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.71%

4.36%

Nächstes Ergebnis

1. Mai 2025

Nächstes Ex-Dividendendatum

12. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-26B

95B

Vorheriger Eröffnungskurs

112.38

Vorheriger Schlusskurs

113.47

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

KKR & Co LP Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Apr. 2025, 06:50 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14. Apr. 2025, 11:46 UTC

Akquisitionen, Fusionen, Übernahmen

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9. Apr. 2025, 10:24 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR

9. Apr. 2025, 07:09 UTC

Akquisitionen, Fusionen, Übernahmen

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7. Apr. 2025, 14:42 UTC

Akquisitionen, Fusionen, Übernahmen

Assura Agrees to Primary Health Properties Bid Deadline Extension

4. Apr. 2025, 10:15 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Gerresheimer Shares Fall After Report That KKR Exited Consortium Seeking Bid

4. Apr. 2025, 09:39 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Drops Out of Consortium Attempting Gerresheimer Takeover, Bloomberg Says, Citing Sources

3. Apr. 2025, 14:57 UTC

Akquisitionen, Fusionen, Übernahmen

Primary Health Proposes $1.95 Billion Bid for Assura -- Update

3. Apr. 2025, 07:17 UTC

Akquisitionen, Fusionen, Übernahmen

Primary Health Proposes $1.95 Billion Bid for Assura

22. Apr. 2025, 06:04 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. Apr. 2025, 06:03 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Biotage Board Recommends Shareholders Accept Offer

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Values Biotage at SEK11.61B

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes SEK145 a Share Bid For Biotage

18. Apr. 2025, 00:00 UTC

Top News

Private Equity World Engulfed by Perfect Storm -- WSJ

14. Apr. 2025, 11:31 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14. Apr. 2025, 11:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14. Apr. 2025, 11:01 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14. Apr. 2025, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14. Apr. 2025, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11. Apr. 2025, 11:56 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Now Owns 30% of Enilive

11. Apr. 2025, 11:55 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Completes Acquisition of Additional Stake in Enilive

9. Apr. 2025, 09:51 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9. Apr. 2025, 09:32 UTC

Akquisitionen, Fusionen, Übernahmen

EQT: Transaction Expected to Close in Coming Months

9. Apr. 2025, 09:31 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR

3. Apr. 2025, 08:17 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Primary Health Properties' Lower Bid for Assura Is a Calculated Risk -- Market Talk

28. März 2025, 09:34 UTC

Akquisitionen, Fusionen, Übernahmen

Topcon: Tender Offer Expected to Start Around End-July >7732.TO

28. März 2025, 09:33 UTC

Akquisitionen, Fusionen, Übernahmen

Topcon: CEO Takashi Eto Also Plans to Participate in Tender Offer, Make Reinvestment After Completion of Offer >7732.TO

28. März 2025, 09:31 UTC

Akquisitionen, Fusionen, Übernahmen

Topcon: JICC Plans to Indirectly Hold Voting Rights in Topcon >7732.TO

28. März 2025, 09:31 UTC

Akquisitionen, Fusionen, Übernahmen

Topcon: KKR Plans to Indirectly Hold Majority Interest in Topcon >7732.TO

Peer-Vergleich

Kursveränderung

KKR & Co LP Prognose

Kursziel

By TipRanks

31.54% Vorteil

12-Monats-Prognose

Durchschnitt 140.5 USD  31.54%

Hoch 194 USD

Tief 114 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für KKR & Co LP – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

11

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

101.87 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m